US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Celon Pharma SA (0RKX) 銘柄情報

Celon Pharma SA (0RKX)

29.00

0.00

( 0.00% )

更新日時： 09:00:00

Celon Pharma SA (0RKX) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

29.00

( - )

買値

29.00

売値

29.00

出来高

0.00

0.00 日の範囲 0.00

29.00 52 週間の範囲 29.00

時価総額

前日終値

29.00

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

PLN 9,074

発行済株式数

53,856,500

配当利回り

PER

-9.08

1 株当たり利益 (EPS)

-2.36

歳入

225.6M

純利益

-122.39M

Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in ... Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. operates as a subsidiary of Glatton Sp. z o.o. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.celonpharma.com

本社

Lomianki, Poland

設立

2026

Celon Pharma SA is listed in the sector of the ロンドン証券取引所 with ticker 0RKX. The last closing price for Celon Pharma was PLN29. Over the last year, Celon Pharma shares have traded in a share price range of PLN 29.00 to PLN 29.00.

Celon Pharma currently has 53,856,500 shares in issue. The market capitalisation of Celon Pharma is PLN1.56 billion. Celon Pharma has a price to earnings ratio (PE ratio) of -9.08.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	29	29	29	0	0	DE
52	0	0	29	29	29	0	0	DE
156	0	0	29	29	29	1997	29	DE
260	0	0	29	29	29	1163	29	DE

0RKX - Frequently Asked Questions (FAQ)

What is the current Celon Pharma SA share price?

The current share price of Celon Pharma SA is PLN 29.00

How many Celon Pharma SA shares are in issue?

Celon Pharma SA has 53,856,500 shares in issue

What is the market cap of Celon Pharma SA?

The market capitalisation of Celon Pharma SA is PLN 1.56B

What is the 1 year trading range for Celon Pharma SA share price?

Celon Pharma SA has traded in the range of PLN 29.00 to PLN 29.00 during the past year

What is the PE ratio of Celon Pharma SA?

The price to earnings ratio of Celon Pharma SA is -9.08

What is the cash to sales ratio of Celon Pharma SA?

The cash to sales ratio of Celon Pharma SA is 5.11

What is the registered address of Celon Pharma SA?

The registered address for Celon Pharma SA is Ogrodowa 2A, Lomianki, 05-092

What is the Celon Pharma SA website address?

The website address for Celon Pharma SA is www.celonpharma.com

Monksdream

Monksdream 1分前

Global Mofy AI Ltd. is a holding company, which engages in AI-Driven technology solutions provider engaged in virtual content production, and digital assets development for the digital content industry. The firm utilizes its “Mofy Lab” technology platform, which consists of 3D rebuilt technology AI

Hi_Lo

Hawkins involved here.

This is NOT a Richard Hawkins company. He is only a consultant. There is a BIG difference. He doesn't run the company nor is he personally invested. He can also be easily over-ruled as a conultant. He can't run this company as he sees fit.

And I c

Monksdream

Monksdream 2分前

GMM, there it goes

QaB2i

“ ….. ( you) would say they are Developed a bit beyond that characterization”
Is that your personal opinion or is that based on non public information?

US Market News

US Market News 6分前

Invitation Homes Announces Cash DividendJune 12, 2026 6:45 AM
Business Wire Invitation Homes Inc. (NYSE: INVH) (“Invitation Homes,” the “Company,” or “our”), the nation’s premier single-family home leasing and management company, announced today that it has declared a quarterly

US Market News

US Market News 6分前

Booz Allen Hamilton to Host Conference Call to Discuss First Quarter Fiscal 2027 Results on Friday, July 24, 2026June 12, 2026 6:45 AM
Business Wire Booz Allen Hamilton Holding Corporation (NYSE: BAH), the parent company of advanced technology company Booz Allen Hamilton Inc.,

US Market News

US Market News 6分前

Build-A-Bear Workshop Completes Planned CEO SuccessionJune 12, 2026 6:45 AM
Business Wire Announces Leadership Updates to Support Continued Business Evolution Build-A-Bear Workshop, Inc. (NYSE: BBW) today announced that Chris Hurt has assumed the role

US Market News

US Market News 6分前

Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 MillionJune 12, 2026 7:00 AM
Business Wire

ScottishTexan

ScottishTexan 8分前

The only reason it’s this high is the sandbox speculation. If it doesn’t happen and ends up being another otc dilution scam that comes in it’ll drop like a stone. The recent purchase of a $100k note for $1k and hiring a guy who graduated last year as a board advisor are not indicative of a multi bil

Investor082

Investor082 10分前

At this point given how long this has gone on despite political support, they are likely debating accepting a very restrictive label with no NICE support for a couple of years at the very least or staying in this limbo for the foreseeable future or accepting rejection.

The new Roswell

Monksdream

Monksdream 12分前

TOP 15
https://www.advfn.com/markets/nasdaq/premarket

HGiLS

It depends who you ask on this board lol.

The only constant valuation is bridge builder’s.

😂

Investor082

Investor082 15分前

By the way, Dr. Analisa Jenkins is not the real deal. Look at all the companies she is involved in on her LinkedIn profile currently. All of them appear well under $100M market cap and many struggling for multiple years. Skye Bioscience, Cocoon, Phaim Pharma, etc.

It appears that NWB

BornAgain

BornAgain 15分前

Looks like the BWMG team is keeping itself busy!!

indepth05

indepth05 16分前

A scoreboard isn’t very impressive when you’re the player, referee, statistician, and sole fan in the stadium. 🤡You call it a scoreboard. Everyone else here calls it self-scoring. 🤡

BornAgain

BornAgain 17分前

https://www.otcmarkets.com/stock/BWMG/news/Brownies-Marine-Group-and-Mountains-to-Seas-to-Showcase-Awake-Electric-Surfboards-at-Atlanta-Foil-Fest?id=524719

TheRealSarsoor

TheRealSarsoor 19分前

Good Morning $HGRAF

US Market News

US Market News 22分前

Vertiv Completes Acquisition of ThermoKey, Expanding Heat Rejection Portfolio for AI Data CentersJune 12, 2026 6:30 AM
PR Newswire (US) Acquisition expected to strengthen thermal management capabilities and manufacturing capacity in Europ

iHub News

iHub News 22分前

Adobe Beats Expectations and Raises Outlook, but Shares Fall on ARR Concerns (ADBE)June 12, 2026 6:25 AM
IH Market News

nowwhat2

nowwhat2 26分前

It depend on dis ;

https://investorshub.advfn.com/uimage/uploads/2026/6/12/kqvogbtc_june_11_6m_SUMMARY_DIE_CUP_200_PLAIN.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/12/oiltidepend_maj.jpg

https://invest

jimmybob

jimmybob 31分前

$SMCI PT lowered to $39 From $45 at Raymond James - keeps Outperform rated

May 6th $35->$45
Feb 6th $50->$35

Investor082

Investor082 31分前

Gary, you seem to be a naive investor. No wonder your perspective of a good pre revenue biotech stock is survival for multiple decades (close to 40 years, LOL).

The market cap of many stocks go down as years go by despite hitting more milestones because investors lose confidence in t

ExtremelyBullishZig

ExtremelyBullishZig 31分前

Should have listened to my extreme bull sh t...huh?
I have been saying that way longer than you...

NASDAQ2020

NASDAQ2020 31分前

How much did THE buyout price just go up ?????🚀

E”TP

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。